Latest blog articles

Globally the majority of health-related R&D is invested in medicines with substantial guaranteed returns, yet what is missing is extensive R&D targeted at diseases overwhelmingly prevalent in developing countries.

Case of Lópex Ribalda and others v.s Spain, ECtHR 09 January 2018 appl. 1874/13 and 8567/13 and Case of Antovic and Mirkovic v. Montenegro, EctHR 28 November 2017, 70838/13

​Call to Participate in a Questionnaire on Dispute Resolution Clauses.

What are the consequences of a possible NEXIT and what are the pros and cons thereof?

Announcing the Technolaweeks!

by Ella Rosenberg

This post is co-written by Dr. Jill Robbie (Glasgow University) and Anna Berlee (MEPLI fellow).